Scinai Immunotherapeutics Ltd.
Last updated September 27, 2026
Organization details
- Legal name
- Scinai Immunotherapeutics Ltd.
- Former names
- BiondVax Pharmaceuticals Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Israel
- Headquarters city
- Jerusalem
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- SCNI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001611747
Board of directors
-
Adi Raviv · DirectorSince 2023
-
Amir Reichman · Director · Chief Executive OfficerSince 2023
-
Avner Rotman · DirectorSince 2023
-
George Lowell · DirectorSince 2023
-
Jay Green · DirectorSince 2023
-
Mark Germain · DirectorSince 2023
-
Morris C. Laster · DirectorSince 2023
-
Samuel J. Moed · DirectorSince 2023
-
Uri Ben-Or · DirectorSince 2026
-
Yael Margolin · DirectorSince 2023
Chief executives
Amir Reichman
· Chief Executive Officer
Since January 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Mark Germain Director | Grant or award | +120,000,000 | — | — |
| Jun 16, 2026 | Amir Reichman Director, Officer (Chief Executive Officer) | Grant or award | +400,000,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.